Analysis of Policies in Activating the Infectious Disease Specialist Network (IDSN) for Bioterrorism Events

생물테러 대비 감염전문가 네트워크 운영 활성화 방안 연구

  • Kim, Yang-Soo (Division of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine)
  • 김양수 (울산대학교 의과대학 서울아산병원 감염내과)
  • Published : 2008.07.31

Abstract

Bioterrorism events have worldwide impacts, not only in terms of security and public health policy, but also in other related sectors. Many countries, including Korea, have set up new administrative and operational structures and adapted their preparedness and response plans in order to deal with new kinds of threats. Korea has dual surveillance systems for the early detection of bioterrorism. The first is syndromic surveillance that typically monitors non-specific clinical information that may indicate possible bioterrorism-associated diseases before specific diagnoses are made. The other is infectious disease specialist network that diagnoses and responds to specific illnesses caused by intentional release of biologic agents. Infectious disease physicians, clinical microbiologists, and infection control professionals play critical and complementary roles in these networks. Infectious disease specialists should develop practical and realistic response plans for their institutions in partnership with local and state health departments, in preparation for a real or suspected bioterrorism attack.

Keywords

References

  1. Gosden C, Gardener D. Weapons of mass destruction: Threats and responses. BMJ 2005; 331(7513): 397-400 https://doi.org/10.1136/bmj.331.7513.397
  2. Rumm PD. Bioterrorism preparedness: Potential threats remain. Am J Public Health 2005; 95(3): 372-375 https://doi.org/10.2105/AJPH.2004.057000
  3. Korea centers for disease control and prevention. Preparedness and response to bioterrorism. [cited 2008 Jul 10]; Available from: URL: http://bioterrorism.cdc.go.kr. (Korean)
  4. Division of Bioterrorism Preparedness and Response, Department of Infectious Disease Control Korea Center for Disease Control and Prevention. Proceeding of International Conference on Bio-Terrorism Preparedness and Response. Seoul: Korea Centers for Disease Control and Prevention; 2006. (Korean)
  5. Division of Bioterrorism Preparedness and Response, Department of Infectious Disease Control Korea Center for Disease Control and Prevention. 2007 Advisory Committee Meeting Material. Seoul: Korea Centers for Disease Control and Prevention; 2007. (Korean)
  6. Division of Bioterrorism Preparedness and Response, Department of Infectious Disease Control Korea Center for Disease Control and Prevention. 2004 Advisory Committee Meeting Material. Seoul: Korea Centers for Disease Control and Prevention; 2004. (Korean)
  7. Division of Bioterrorism Preparedness and Response, Department of Infectious Disease Control Korea Center for Disease Control and Prevention. 2005 Infectious Disease Specialist Seminar. Seoul: Korea Centers for Disease Control and Prevention; 2005. (Korean)
  8. Division of Bioterrorism Preparedness and Response, Department of Infectious Disease Control Korea Center for Disease Control and Prevention. 2005 Advisory Committee Meeting Material. Seoul: Korea Centers for Disease Control and Prevention; 2005. (Korean)
  9. The Research Group for Evaluation of Bioterrorism Management. Proceeding of Workshops for Evaluation of Bioterrorism Preparedness and Response. Wonju: Yonsei Wonju Medical College; 2006. (Korean)
  10. Bravata DM, McDonald KM, Smith WM, Rydzak C, Szeto H, Buckeridge DL, et al. Systematic review: Surveillance systems for early detection of bioterrorism-related diseases. Ann Intern Med 2004; 140(11): 910-922 https://doi.org/10.7326/0003-4819-140-11-200406010-00013
  11. National Library of Medicine. Medline Plus: Biodefense and bioterrorism. [cited 2008 Jul 10]; Available from: URL:http://www.nlm. nih.gov/medlineplus/biodefenseandbioterroris m.html.
  12. National Institute of Allergy and Infectious Disease. Biodefense and related program. [cited 2008 Jul 10]; Available from: URL: http://www.niaid.nih.gov/Biodefense
  13. Meadows M. The FDA and the fight against terrorism. FDA Consum Mag [serial online] 2004 Jan-Feb [cited 2008 Jul 10]; 38(4). Available from: URL:http://www.fda.gov/ fdac/features/2004/104_terror.html
  14. Werner D, Wright K, Thomas M, Edgar M. An innovation in partnership among first responders and public health: Bridging the gap. Public Health Rep 2005; 120( Suppl 1): 64-68 https://doi.org/10.1177/00333549051200S113
  15. Fan J, Kraft AJ, Henrickson KJ. Current methods for the rapid diagnosis of bioterrorismrelated infectious agents. Pediatr Clin North Am 2006; 53(5): 817-842 https://doi.org/10.1016/j.pcl.2006.08.002